A phase 1-2 study of imexon plus dacarbazine in patients with unresectable metastatic melanoma.
about
Upsides and downsides of reactive oxygen species for cancer: the roles of reactive oxygen species in tumorigenesis, prevention, and therapyPhase 2 study of imexon, a prooxidant molecule, in relapsed and refractory B-cell non-Hodgkin lymphomaAnti-tumor activity and mechanism of action for a cyanoaziridine-derivative, AMP423.Magnetic Resonance Imaging Identifies Differential Response to Pro-Oxidant Chemotherapy in a Xenograft Model.Oxidative stress and therapeutic opportunities: focus on the Ewing's sarcoma family of tumors.
P2860
A phase 1-2 study of imexon plus dacarbazine in patients with unresectable metastatic melanoma.
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
A phase 1-2 study of imexon pl ...... esectable metastatic melanoma.
@ast
A phase 1-2 study of imexon pl ...... esectable metastatic melanoma.
@en
type
label
A phase 1-2 study of imexon pl ...... esectable metastatic melanoma.
@ast
A phase 1-2 study of imexon pl ...... esectable metastatic melanoma.
@en
prefLabel
A phase 1-2 study of imexon pl ...... esectable metastatic melanoma.
@ast
A phase 1-2 study of imexon pl ...... esectable metastatic melanoma.
@en
P2093
P356
P1433
P1476
A phase 1-2 study of imexon pl ...... esectable metastatic melanoma.
@en
P2093
Antoni Ribas
Evan Hersh
Jeffrey S Weber
Joe Stephenson
Kathryn Grenier
Rene Gonzalez
Robert Dorr
Steven O'Day
Takami Sato
P304
P356
10.1002/CNCR.25119
P407
P577
2010-08-01T00:00:00Z